Back to results
US 2023/0056202 A1Published application
Anti-malarial agents
AssigneesBoard of Regents, The University of Texas System, Mmv Medicines for Malaria Venture
InventorsMARGARET PHILLIPS, MICHAEL PALMER, SUSAN A. CHARMAN, KARL SHAWN WATTS, ALEKSEY I. GERASYUTO, GORAN KRILOV
Life of this patent
Estimating the term…
Abstract
The present invention is related to new pyrrole derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to pyrrole derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.
Claims23
1-24. (canceled)
A compound according to Formula (I):
- wherein R1 is an optionally substituted 5-membered heterocycle such as an optionally substituted triazole, such as optionally substituted 1, 2, 4 triazole (e.g. 1, 2, 4 triazole), or optionally substituted pyrazole (1H-pyrazole-5-carboxamide) such as optionally substituted pyrazole-4-yl (e.g. 1H-pyrazol-4-yl, 1-methyl-pyrazol-4-yl) or optionally substituted pyrazole-3-yl (e.g. 5-methyl-1H-pyrazol-3yl, 5-cyano-1H-pyrazol-3-yl) or an optionally substituted imidazole such as an optionally substituted imidazole-4-yl (e.g. imidazole-4-yl) or an optionally substituted isoxazole such as an optionally substituted isoxazol-3-yl (e.g. 5-methylisoxazol-3-yl);
- R2 is H or both R2 are joined to form an optionally substituted cyclopropyl;
- R3 is selected from an optionally substituted monocyclic aryl such as an optionally substituted phenyl (3-fluoro-4-(trifluoromethyl)phenyl) and an optionally substituted heteroaryl such as optionally substituted pyridinyl, for example optionally substituted pyridin-3-yl (e.g. trifluoromethyl) pyridin-3-yl, di-fluoro-methyl pyridin-3-yl;
- as well as pharmaceutically acceptable salts, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof.
1 more element
Dependencies are inferred from the claim text.